Ennis revenue rises 3.3% to $102 million
Ennis (NYSE:EBF) reported revenue of $102 million for the quarter ended August 31, 2026, an increase of $3.3 million, or 3.3%, compared with the same period last year.
Ennis (NYSE:EBF) reported revenue of $102 million for the quarter ended August 31, 2026, an increase of $3.3 million, or 3.3%, compared with the same period last year.
Cue Biopharma (NASDAQ:CUE) shares gained after the company reported positive results from a mid-stage study evaluating CUE-221 as a treatment for hives.
Paramount Skydance (NASDAQ:PSKY) and Warner Bros. Discovery (NASDAQ:WBD) shares gained after reports that Paramount Skydance was advancing settlement discussions with California’s attorney general over the proposed merger.
Accenture (NYSE:ACN) shares rose after the company announced a partnership with AI lab Anthropic to support artificial intelligence model evaluation and testing.
Novo Nordisk (NYSE:NVO) shares declined after the company presented its strategic ambitions for 2030 ahead of its Capital Markets Day, including long-term pipeline and obesity market targets.
nVent Electric (NYSE:NVT) declared a regular quarterly cash dividend of $0.21 per ordinary share, payable on November 6, 2026, to shareholders of record as of October 23, 2026.
Cadeler (NYSE:CDLR) signed a memorandum of understanding with Vattenfall to develop next-generation offshore wind operations and maintenance solutions through Cadeler’s Nexra service platform.
Asian shares mostly moved higher on Monday as investors monitored developments ahead of an expected meeting between U.S. President Donald Trump and Chinese President Xi Jinping covering trade, artificial intelligence and geopolitical issues.
The Bank of Russia has proposed limiting banks’ cryptocurrency and foreign digital-instrument risk to 1% of their own funds.
Brent crude and West Texas Intermediate oil prices declined to their lowest levels in about a week as traders responded to renewed hopes for a diplomatic solution to the Middle East conflict.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy